Design,Synthesis and Antitumor Activity of Novel Indolin-2-one Derivatives Containing 4-Thiazolidinone Moiety

A series of novel indolin-2-one derivatives containing 4-thiazolidinone moiety(7a―7r) were synthesized and evaluated for their in vitro antitumour activities against MDA-MB-231(human breast cancer), H460(human lung cancer) and HT-29(human colon cancer) cell lines by standard 3-(4,5-dimethylthiazae-2-yl)-2,5-diphenyltetrazo- lium bromide(MTT) assay. Representative compounds(7d, 7k, 7m, 7p) with higher cytotoxicity were further examined against one normal cell line(WI-38, human fetal lung fibroblasts). The preliminary investigation shows that most of the compounds display moderate to excellent potency and high selectivity against different human cancer cell lines. In particular, the most potent compound 7m shows promising cytotoxicity against MDA-MB-231, H460 and HT-29 cell lines with IC₅₀ values of 0.78, 0.056 and 0.018 μmol/L, respectively. The potency is much higher than that of Sunitinib(IC₅₀=3.46 μmol/L against MDA-MB-231, IC₅₀=2.59 μmol/L against H460, IC₅₀=1.50 μmol/L against HT-29) by 4.4, 46.3 and 83.3 fold.     

Synthesis and Antitumor Activity of Sorafenib Analogs Containing a Tetrazole Moiety

A novel series of diaryl biuret derivatives containing a tetrazole moiety was designed and synthesized.All the target compounds were evaluated for their in vitro antitumor activity against HT-29,HepG2,MCF-7 and A549 cells by MTT assay.Most of them exhibited obvious antitumor activity,and four of them(4a,4c,4h and 7a)were superior to sorafenib in general.Among them,Compound 4h displayed more potent activity than sorafenib in all tested cancer cells.Compound 4c exhibited the most outstanding activity in inhibition of growth of HepG2 cells(IC50=0.55 μmol/L).Further,they both revealed favorable metabolic stability in in vitro assay.Compounds 4c and 4h are promising candidates for further development.     

Design,Synthesis and Pharmacological Evaluation of Novel 4-Phenoxyquinoline Derivatives as Potential Antitumor Agents

A series of novel 4-phenoxyquinoline derivatives containing 3-amino-2-cyano-acrylamide framework was designed and synthesized, and the in vitro cytotoxic activities of them against five cancer cell lines(HT-29, H460, A549, MKN-45, and U87MG) were evaluated. Most of the compounds exhibited moderate-to-significant cytotoxicity and high selectivity against one or more cell lines as compared with Foretinib. The studies of their preliminary structure-activity relationships(SARs) indicate that the compounds containing methyl groups, especially methyl groups at 4-position of the phenyl ring(moiety B) are more effective. Among them, compound 36 shows the most potent antitumor activities with IC₅₀ values of 0.04, 0.09, 0.67, 0.39 and 1.10 μmol/L against HT-29, H460, A549, MKN-45 and U87MG cell lines, respectively.     

含4-氨基哌啶片段的6,7-二甲氧基喹啉衍生物的合成及抗肿瘤活性

以2-氨基-4,5-二甲氧基苯甲酸（2）和环酮（环戊酮、环己酮）为原料,在三氯氧磷作用下“一锅法”合成6,7-二甲氧基喹啉中间体（3）,再与4-氨基哌啶或4-异丙基-1-氨基环己烷（4）发生Buchwald-Hartwig偶联反应,得到含有4-氨基哌啶或4-异丙基-1-氨基环己烷片段的6,7-二甲氧基喹啉衍生物（1a～1f）,产物及中间体结构通过¹H NMR、¹³C NMR、MS及元素分析进行表征。初步抗肿瘤活性测试表明,所合成化合物对HepG2、MCF-7、PC3和HeLa均有明显的抑制活性,尤其是化合物1b展现出较强的MCF-7抑制活性(IC₅₀ =11.2μmol/L),甚至强于当前乳腺癌的一线治疗药物4-羟基他莫昔芬(IC₅₀ =15.1μmol/L);此外,标题化合物对正常的乳腺上皮细胞MCF-10A没有毒性。     

Synthesis and Antibacterial Activity of Oxazolidinone Derivatives Containing Nitro Heteroaromatic Moiety

A series of novel oxazolidinone derivatives containing nitro heteroaromatic moiety was synthesized and characterized by means of ¹H NMR and MS spectra. All target compounds were evaluated for their in vitro antibacterial activities against S.au 29213, methicillin-resistant Staphylococcus aureus(MRSA) and vancomycin-resistant Enterococcus(VRE) by minimum inhibitory concentration(MIC) assay. Most of them exhibited antibacterial activity against S. au 29213, MRSA and VRE. Among them, compounds 10e and 10f displayed better activity than the control.     

Design,Synthesis, and Antitumor Activity of Olmutinib Derivatives Containing Acrylamide Moiety

Two series of olmutinib derivatives containing an acrylamide moiety were designed and synthesized, and their IC₅₀ values against cancer cell lines (A549, H1975, NCI-H460, LO2, and MCF-7) were evaluated. Most of the compounds exhibited moderate cytotoxic activity against the five cancer cell lines. The most promising compound, H10, showed not only excellent activity against EGFR kinase but also positive biological activity against PI3K kinase. The structure–activity relationship (SAR) suggested that the introduction of dimethylamine scaffolds with smaller spatial structures was more favorable for antitumor activity. Additionally, the substitution of different acrylamide side chains had different effects on the activity of compounds. Generally, compounds H7 and H10 were confirmed as promising antitumor agents.     

取代噻吩双酰胺类化合物的设计、 合成及生物活性

利用中间体衍生化方法, 将噻吩环引入到双酰胺类化合物中, 合成了一系列取代噻吩双酰胺类化合物1~3; 目标化合物的结构经核磁共振波谱、 红外光谱及元素分析确认. 生物活性测试结果表明, 化合物1在600 mg/L剂量下对小菜蛾具有良好的杀虫效果, 致死率均为100%, 其中化合物1a和1e在20 mg/L剂量下对小菜蛾的致死率仍达到60%以上; 改变双酰胺结构中的吡唑环得到化合物2和3, 其杀虫活性消失, 说明该类化合物中吡唑环结构对杀虫活性具有关键作用.     

Synthesis and Antitumor Activity Evaluation of Pyrimidine Analogues Bearing Urea Moiety

A series of 4‐anilino‐6‐phenylpyrimidines containing urea moiety were synthesized and the structures of all products were confirmed by ¹H NMR, ¹³C NMR and HRMS. The antiproliferative activities of these compounds were evaluated against three human tumor cell lines (MGC‐803, MCF‐7 and EC‐109) by applying the MTT assay method. compounds 4a , 4b and 6a showed the most effective activity, among which, 6a was more cytotoxic than 5‐fluorouracil against all tested human cancer cell lines with IC₅₀ values ranging from 1.80 to 2.72 µmol·L^?1.     

新型吲唑类化合物的合成及其抗肿瘤活性

以2,6-二氟苯腈与吗啉反应制得2-氟-6-吗啉-苯腈(1); 1与水合肼在N-甲基吡咯烷酮中通过环合反应制得3-氨基-4-吗啉-1H-吲唑(2); 2与不同羧酸经缩合反应合成了8个新型吲唑类化合物(4a~4h),其结构经¹H NMR, IR和HR-ESI-MS表征。抗肿瘤活性测试结果表明：3,4,5-三甲氧基-氮-(4-吗啉-1H-吲唑-3-基)苯甲酰胺（4a）的抗肿瘤活性最好,对K-562, SMMC7721和T-47D肿瘤细胞有明显抑制作用,IC₅₀分别为0.056 μmol·L^-1, 0.062 μmol·L^-1和0.078 μmol·L^-1。     

新型含三氟甲基喹唑啉衍生物的设计合成及抗肿瘤活性研究

为了从喹唑啉衍生物中寻找高活性的抗肿瘤分子,以2-氨基苯甲酰胺为原料,经过三氟乙酰化、环化、氯代以及偶联反应等,合成了21个2-三氟甲基喹唑啉类化合物,并通过¹H NMR、¹³C NMR、¹⁹F NMR进行结构确证。采用四唑盐（MTT）法评价目标化合物的体外抗肿瘤活性,结果表明,部分所合成的喹唑啉衍生物对人前列腺癌细胞（PC3、LNCaP）、人慢性髓系白血病细胞（K562）、宫颈癌细胞（Hela）以及人肺癌细胞（A549）具有抗增殖活性,其中活性较好的化合物5a和5b在5μmol/L时对LNCaP细胞增殖的抑制活性分别为61.7%、62.8%。此外N-甲基化产物5a和5b的体外抗肿瘤活性较原型化合物（4a和4b）显著提高,这为该类化合物的深入研究提供了参考依据。     

Synthesis and Herbicidal Activity of Novel Sulfonylureas Containing 1,2,4-Triazolinone Moiety

A series of new sulfonylureas incorporating 1,2,4-triazolinone moiety was synthesized, which were further bio-assayed for the herbicidal activity against four herbs, representative of monocotyledons and dicotyledons. Some of them exhibited high potency to inhibit the growth of dicotyledons(Bassica napus and Amaranthus retroflexus) in the pot experiment. Compounds 9a and 9b also displayed an excellent herbicidal activity against Bassica napus at a concentration of 15 g/hectare, which were comparable with commercial triasulfuron.     

Novel Phosphoranes Containing Urea Derivatives: Synthesis and Characterization

N-Acetyl-N′-methyl urea or ethyl urea in the presence of an acetylenic ester and a desired phosphine functioned as a NH-acid and added to the triple bond in a chemoselective reaction. One of the obtained products underwent lactonization to the corresponding imidazolidine containing ylide moiety when heated in the presence of a base such as triethyl amine.     

含喹唑啉硫醚的杨梅素衍生物的设计、合成及生物活性研究

以杨梅苷为原料,通过活性拼接,设计并合成一系列含喹唑啉硫醚的杨梅素衍生物,其结构通过1H NMR、13CNMR、19F NMR和HRMS进行确证.生物活性测试结果表明,该类化合物对水稻白叶枯病菌(X.Oryzae)、柑橘溃疡病菌(X.Citri)和烟草青枯病菌(R.Solanacearum)表现出一定的抑制活性.其中,...     

含有单取代嘧啶的新型磺酰脲类化合物的设计、合成及除草活性

为了寻找高效的磺酰脲类除草剂, 以商品化磺酰脲类除草剂为基础, 将单取代嘧啶结构引入到分子中, 合成了一系列新型磺酰脲类化合物, 并通过¹H NMR和高分辨质谱确定了其结构. 采用盆栽法和平皿法测试了所有化合物的除草活性以及部分化合物对油菜的IC₅₀值. 结果表明, 一些化合物具有一定的除草活性, 其中化合物7b和7d对油菜和反枝苋具有较好的抑制活性.     

Novel Thiochromanone Derivatives Containing a Sulfonyl Hydrazone Moiety: Design,Synthesis, and Bioactivity Evaluation

A series of novel thiochromanone derivatives containing a sulfonyl hydrazone moiety were designed and synthesized. Their structures were determined by ¹H-NMR, ¹³C-NMR, and HRMS. Bioassay results showed that most of the target compounds revealed moderate to good antibacterial activities against Xanthomonas oryzae pv. oryzae, Xanthomonas oryzae pv. oryzicolaby, and Xanthomonas axonopodis pv. citri. Compound 4i had the best inhibitory activity against Xanthomonas oryzae pv. oryzae, Xanthomonas oryzae pv. oryzicolaby, and Xanthomonas axonopodis pv. citri, with the EC₅₀ values of 8.67, 12.65, and 10.62 μg/mL, which were superior to those of Bismerthiazol and Thiodiazole-copper. Meanwhile, bioassay results showed that all of the target compounds proved to have lower antifungal activities against Sclerotinia sclerotiorum, Fusarium oxysporum, Gibberella zeae, Rhizoctonia solani, Verticillium dahlia, and Botrytis cinerea than those of Carbendazim.     

含苯并噻唑砌块的2,4,6-三取代嘧啶衍生物的合成及抗肿瘤活性评价(英文)

为了寻找高效的抗肿瘤药物,设计并合成了一系列含苯并噻唑砌块的2,4,6-三取代嘧啶衍生物.采用噻唑蓝(MTT)法对目标化合物在人类四种癌细胞[EC-109(人食管癌细胞)、MGC-803(人胃癌细胞)、PC-3(人前列腺癌细胞)、Hep G-2(人肝癌细胞)]、GES-1(人正常胃黏膜上皮细胞)和HEEC(人正常食管细胞)中进行抗肿瘤活性评价,结果显示部分化合物对MGC-803和PC-3细胞表现出中度至强效的抗肿瘤活性.其中2-(((4-(4-(吡啶-2-基)哌嗪-1-基)-6-(三氟甲基)嘧啶-2-基)硫基)甲基)苯并[d]噻唑(13h)和2-(((4-(4-(嘧啶-2-基)哌嗪-1-基)-6-(三-氟甲基)嘧啶-2-基)硫代)甲基)苯并[d]噻唑(13i)对PC-3表现出比较好的抗肿瘤活性, IC50值分别3.82和2.29μmol/L,且化合物13h和13i对GES-1的细胞增值毒性明显小于阳性对照5-氟尿嘧啶.     

Design,Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives Bearing Semicarbazone Moiety as Antitumor Agents

A series of novel benzothiazole derivatives bearing semicarbazone as a linker was designed and synthesized, and their in vitro antitumor activities were evaluated against four cancer cell lines(HT29, H460, A549 and MDA-MB-231). Most of them showed moderate to excellent activity against all the tested cell lines. Among them, compounds 12a―12i with fluoro-substituted benzyl-1H-indole moiety displayed more potent activity than those with phenyl moiety. The most promising compound 12d exhibited excellent antitumor activity with IC₅₀ values of 0.015, 0.28, 1.53 and 0.68 μmol/L against the four tested cell lines respectively.     

二肽类膦酸酯衍生物的合成与抗肿瘤活性

为了寻找抗肿瘤活性化合物,以前期研究的含一个氨基酸结构单元的膦酸酯衍生物为基础,设计合成了15个二肽类膦酸酯衍生物(Ⅲa-Ⅲo).采用溴化噻唑蓝四氮唑(MTT)法进行体外抗肿瘤活性测试.结果表明:该类化合物对人肺癌细胞(A-549)、人胃癌细胞(SGC-7901))和人食管癌细胞(EC-109)有潜在增殖抑制作用.其中...     

甘草次酸衍生物的合成及其抗癌活性

设计合成了6种甘草次酸衍生物,用元素分析、波谱分析鉴定了它们的结构,并比较了它们的体内、体外抗癌活性,均表现出较好的活性,尤其是化合物Ⅰa,Ⅰb口服效果比盐酸氮芥还好,表现出甘草次酸对氮芥有明显的增效应用。     

Novel Fluorinated 7-Hydroxycoumarin Derivatives Containing an Oxime Ether Moiety: Design,Synthesis, Crystal Structure and Biological Evaluation

A series of fluorinated 7-hydroxycoumarin derivatives containing an oxime ether moiety have been designed, synthesized and evaluated for their antifungal activity. All the target compounds were determined by ¹H-NMR, ¹³C-NMR, FTIR and HR-MS spectra. The single-crystal structures of compounds 4e, 4h, 5h and 6c were further confirmed using X-ray diffraction. The antifungal activities against Botrytis cinerea (B. cinerea), Alternaria solani (A. solani), Gibberella zeae (G. zeae), Rhizoctorzia solani (R. solani), Colletotrichum orbiculare (C. orbiculare) and Alternaria alternata (A. alternata) were evaluated in vitro. The preliminary bioassays showed that some of the designed compounds displayed the promising antifungal activities against the above tested fungi. Strikingly, the target compounds 5f and 6h exhibited outstanding antifungal activity against B. cinerea at 100 μg/mL, with the corresponding inhibition rates reached 90.1 and 85.0%, which were better than the positive control Osthole (83.6%) and Azoxystrobin (46.5%). The compound 5f was identified as the promising fungicide candidate against B. cinerea with the EC₅₀ values of 5.75 μg/mL, which was obviously better than Osthole (33.20 μg/mL) and Azoxystrobin (64.95 μg/mL). Meanwhile, the compound 5f showed remarkable antifungal activities against R. solani with the EC₅₀ values of 28.96 μg/mL, which was better than Osthole (67.18 μg/mL) and equivalent to Azoxystrobin (21.34 μg/mL). The results provide a significant foundation for the search of novel fluorinated 7-hydroxycoumarin derivatives with good antifungal activity.